NCT01582893View on ClinicalTrials.gov

Permeability Enhancement to Reduce Chronic Inflammation

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

July 31, 2013

Conditions
End Stage Renal DiseaseInflammation
Interventions
DEVICE

HCO1100

Dialysis

DEVICE

P210H

Dialysis

Trial Locations (2)

10625

KfH-Bismarkstrasse 95-96, Berlin

06120

KfH Bachstzelzenweg 4, Halle

All Listed Sponsors
collaborator

Gambro Dialysatoren GmbH

INDUSTRY

collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Vantive Health LLC

INDUSTRY

NCT01582893 - Permeability Enhancement to Reduce Chronic Inflammation | Biotech Hunter | Biotech Hunter